REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 156 filers reported holding REGENXBIO INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,157,000 | -31.5% | 63,250 | -8.9% | 0.00% | 0.0% |
| Q4 2020 | $3,148,000 | +61.4% | 69,400 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $1,951,000 | -23.1% | 70,900 | +2.9% | 0.00% | -33.3% |
| Q2 2020 | $2,538,000 | +15.3% | 68,900 | +1.3% | 0.00% | 0.0% |
| Q1 2020 | $2,202,000 | -25.3% | 68,000 | -5.4% | 0.00% | 0.0% |
| Q4 2019 | $2,946,000 | +30.8% | 71,900 | +13.6% | 0.00% | +50.0% |
| Q3 2019 | $2,253,000 | +101.5% | 63,300 | +190.9% | 0.00% | +100.0% |
| Q2 2019 | $1,118,000 | -31.2% | 21,757 | -23.2% | 0.00% | -50.0% |
| Q1 2019 | $1,624,000 | +35.7% | 28,343 | -0.7% | 0.00% | 0.0% |
| Q4 2018 | $1,197,000 | -46.7% | 28,543 | -4.0% | 0.00% | -33.3% |
| Q3 2018 | $2,246,000 | +55.4% | 29,743 | +47.7% | 0.00% | +50.0% |
| Q2 2018 | $1,445,000 | – | 20,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |